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Background: Amyotrophic lateral sclerosis (ALS) and its devastating neurodegenerative
consequences have an inevitably psychological impact on patients and their caregivers:
however, although it would be strongly needed, there is a lack of research on the efficacy
of psychological intervention. Our aim was to investigate the effect of hypnosis-based
intervention on psychological and perceived physical wellbeing in patients and the indirect
effect on caregivers. Methods:We recruited eight ALS volunteers patients as a pilot sam-
ple for an hypnosis intervention and self-hypnosis training protocol lasting 1 month. Anxiety
and depression level was measured in patients and caregivers at pre and post treatment
phase. Quality of life and perceived physical symptoms changes were also investigated
in patients. Results: One month pre-post treatment improvement in depression, anxiety,
and quality of life was clearly clinically observed and confirmed by psychometric analyses
on questionnaire data. Moreover, decreases in physical symptoms such as pain, sleep dis-
orders, emotional lability, and fasciculations were reported by our patients. Improvements
in caregiver psychological wellbeing, likely as a consequence of patients psychological and
perceived physical symptomatology improvement, were also observed. Conclusion: To
the best of our knowledge, even if at a preliminary level, this is the first report on efficacy
psychological intervention protocol on ALS patients.The findings provide initial support for
using hypnosis and self-hypnosis training to manage some ALS physical consequences
and mainly to cope its dramatic psychological implications for patients and, indirectly, for
their caregivers.
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INTRODUCTION
Amyotrophic Lateral Sclerosis (ALS) is classically characterized
by progressive loss of upper and lower motor neurons, causing
weakness and hypotrophy of upper and lower limbs, dyspha-
gia and dysarthria, and respiratory failure, which is the most
common cause of death. Frequently, patients require intubation
and mechanical ventilation and, in a large proportion, receive
tracheostomy, leading to inevitably, overwhelming locked-in syn-
drome (Vianello et al., 2011). Secondary symptoms that affects
patient quality of life are also pain (Pagnini et al., 2011a; Chiò
et al., 2012; Pagnini, 2012), sleep disorders (Blackhall, 2012), emo-
tional lability (Palmieri et al., 2009), and fasciculations (Rana
et al., 2009; De Carvalho and Swash, 2012). Although pharma-
cology and physiotherapy research efforts, effective treatments
for ALS have remained elusive (Beghi et al., 2011). Not surpris-
ingly, a very active community of researchers is dedicated to
deepen the devastating psychological impact of ALS in patients
and caregivers. Depression and anxiety are two reactions typi-
cally described in response of the disease, mainly in the first stage,
in which are accompanied by anger, hopelessness, and suicidal
ideation (Palmieri et al., 2010a; Pagnini, 2012). Patient psychic
status has been found directly related to caregiver’s one (Palmieri
et al., 2009; Pagnini et al., 2010a, 2011b). Analogously, caregiver
psychological status has a deep impact on patient (Chiò et al.,
2005). Although psychological wellbeing is crucial also in deter-
mining a better prognosis in ALS (McDonald et al., 1994), there is
an absence of research on efficacy of psychological intervention in
ALS. That is what was recently highlighted by Pagnini et al. (2012),
in a relevant short communication published in ALS leading jour-
nal, eloquently entitled: “ALS: time for research on psychological
intervention?” The communication arises the importance to carry
out exploratory investigation on the impact and the suitability
of psychological treatments for ALS patients. Given the devastat-
ing physical involvement of the disease, which affects also speech
ability and eventually may result in the locked-in syndrome, a
mind-body treatment technique, such as hypnosis, mindfulness
meditation, or biofeedback (techniques included among com-
plementary therapies in neurology; Wahbeh et al., 2008), could
represent the eligible psychological forms of intervention. In par-
ticular, probably no other contemporary therapeutic intervention
has a longer and corroborated clinical/scientific history than that
of hypnosis. Our purpose was to explore, in the form of a pilot
study, the applicability and efficacy of a hypnosis-based treatment
in a small sample of ALS patients. Since the potential treatment
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benefit obtained from individual active participation (Bandura,
1997), a self-hypnosis training, other than ericksonian hypno-
sis classical intervention, was proposed to patients. Our primary
hypothesis was that the treatment and the training may determine
relevant reductions in the two primary psychological reactions to
the disease, i.e., anxiety and depression, and, in general, in qual-
ity of life. In addition, we aimed to explore if the participation
to the hypnosis training could produce significant improvements
in the perception of the above-mentioned physical secondary
symptomatology (i.e., pain, sleep disorders, emotional lability,
and fasciculations). Finally, we hypothesized an eventual reduc-
tion of caregivers’ anxiety and depression, as indirect consequence
of patients psychological improvement.
MATERIALS AND METHODS
PARTICIPANTS AND PROCEDURE
Eight consecutive patients with a diagnosis of probable or def-
inite ALS (in accordance with the Revised El Escorial Criteria;
Brooks et al., 2000) presenting to the Motor Neuron Disease Cen-
ter of Padova University Hospital and their respective caregivers
(seven spouses, one daughter) were recruited as volunteers for
the pilot study. Patients underwent complete neurological and
neuropsychological examination within a week before the first
treatment session. Our sample was composed by four males and
four females, with mean age of 55 years (SD= 7.14); ALSFRS-r
(Cedarbaum et al., 1999) mean score was 35 (SD= 7.1), ranging
from 21 to 42; four had bulbar onset, and one of them was com-
pletely enable to speak; two were completely enable to move upper
limbs. Patient neuropsychological profiles did not revealed any
alteration if compared to normative data. Further demographic
and clinical characteristics of participants are reported in Table 1.
The intervention protocol consisted of four weekly domiciliary
sessions of hypnosis-based intervention, administered by a psy-
chologist extensively trained in ericksonian hypnotic method and
analgesic hypnosis. All sessions were based on a standardized,
general induction followed by individual suggestion modified for
the patient according to his/her psychological status and physi-
cal symptoms. Hypnotic suggestions were constituted by guided
visual imagery oriented with an emphasis on developing physi-
cal symptomatology controls, such as muscle pain or emotional
lability, sense of resilience, self-consciousness, and illness accep-
tance. After the hypnosis session, which lasted about 45 min,
patient was supported by the aiding of the hypnotherapist to
try again in recreating hypnotic status with self-hypnosis tech-
nique. The general induction, common for all treatment phases
and for all patients, was recorded in a CD audio and was left to
each patient who was encouraged to practice at least one time
every day. Such procedure is inspired by Jensen et al. (2009, 2011)
hypnosis-based protocol, successfully applied on multiple sclero-
sis patients. Sessions included also a brief clinical interview with
patient and/or caregiver (separately) collected by a psychotherapist
with 10-years experience with ALS. The interview aimed to inves-
tigate the subjective perception of the hypnosis treatment efficacy
both on psychological and physical perspective, the frequency of
application and the eventual difficulties. Each entirely domiciliary
session lasted about 2 h. Immediately before the first and after the
last treatment, patients and caregivers psychological variables were
collected by means of standardized, Italian-validated ad hoc ques-
tionnaires, as described in the next paragraph. Patient impressions
on physical symptomatology were also systematically recorded.
The study protocol was approved by the Ethical Committee of
the University of Padova and carried out in accordance with the
principles of the Declaration Helsinki as revised in 1983. All the
participants signed a consent statement after being informed about
the study’s purpose and methods.
MEASURES
The Hospital Anxiety and Depression Scale (HADS; Zigmond
and Snaith, 1983), a measure largely used to identify caseness of
anxiety disorders and depression among non-psychiatric patients
(Bjelland et al., 2002), easy to administer and well accepted, was
employed for patients and their caregivers. It is divided into an
Anxiety subscale (HADS-A) and a Depression subscale (HADS-
D) both containing seven intermingled items on a 4-point Likert
scale (ranging 0–3).
Patients also underwent the Amyotrophic Lateral Sclerosis Spe-
cific Quality of Life – revised (ALSSQOL-r; Simmons et al.,
2006; Pagnini et al., 2010b), a 46-items on a 11-point Likert
scale (ranging 0–10) derived from interviews with ALS patients.
The ALSSQOL-r is composed by six subscale including negative
Table 1 | Participants demographic and clinical characteristics.
Patient Age Gender Time since
diagnosis (months)
Onset ALSFRS-r FVC (%) Caregivers age
(years); gender
I 64 F 24 Bulbar 42 82 (32); F*
II 55 M 15 Limb 38 82 (50); F
III 59 F 10 Limb 40 86 (57); M
IV 54 M 26 Limb 21 56 (50); F
V 43 M 18 Limb 39 92 (40); F
VI 53 M 40 Limb 30 75 (53); F
VII 55 F 24 Bulbar 39 91 (56); M
VIII 66 F 10 Limb 31 72 (69); M
ALS-FRS-r, amyotrophic lateral sclerosis functional rating scale-revised; FVC, forced vital capacity.
*Daughter; in the other cases, caregiver was the spouse.
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emotion (13 items), interaction with people and their environ-
ment (11 items), intimacy (seven items), religiousness and spir-
ituality (four items), physical symptoms (six items), and bulbar
functioning (five-items).
The five-items ALS Assessment Questionnaire (ALSAQ-5), a
further, brief specific quality of life measure derived from the
broader ALSAQ-40 (Jenkinson and Fitzpatrick, 2001; Palmieri
et al., 2010b), was also administered to patients. Items are com-
posed on a five-point Likert scale (ranging 1–5). Such measure
was introduced, in addition to the more exhaustive, even if dif-
ferent in content, ALSSQOL-r, in the perspective of eventual 3
and 6 months follow-up, in order to obviate eventual drop out
in quality of life measurement (such phenomenon could be due
to progressive physical impairment that can frustrate responding
questionnaire with many items).
Global satisfaction with hypnotic-based intervention score in
terms of perceived efficacy was assessed asking patients to rate,
after treatment, how satisfied they were with the treatment they
received on a 1–5 Likert scale (from one as totally unsatisfied to
five as extremely satisfied). Subjective perception of secondary
symptoms affecting patient everyday life that could receive bene-
fit from hypnosis-based treatment, namely pain, sleep disorders,
emotional lability, and fasciculations, were qualitatively investi-
gated before and after the treatment (for an example, in the
time lapse immediately preceding the beginning of the treatment
were asked to the patients: “Did you suffer physical pain (e.g.,
cramps)?” And, if yes, after the treatment was asked them: “Did
you notice any improvement during the training period?”). To
not overfatigue the patients with wide many items standardized
measurements, we opted, at this preliminary level, to investi-
gate such physical perceived changes with a simple open-answers
interview, avoiding dimension-specific questionnaires for pecu-
liar physical dysfunctions. Due to severity of motor impairment,
not every patient would be able to fulfill self-report questionnaires
responses. Therefore, to obviate eventual heterogeneity in the data
collection, a trained psychologist administered all questionnaires
in an eterodirected way.
DATA ANALYSIS
Pre-post differences in scores for each subscale of the question-
naires (HADS, ALSSQOL, ALSAQ-5) were analyzed for signifi-
cance through Wilcoxon Signed Rank Tests at the 0.05 level, and the
Cliff ’s delta (∂) statistic was used to assess effect size. Cliff ’s delta
(Cliff, 1993) was chosen as a more robust alternative to the com-
mon Cohen’s d in conditions were non-parametric statistics are
advisable, such as small sample sizes where it is not safe to assume
a normal distribution (Hess and Kromrey, 2004). An high effect
size is considered ∂ ≥ |0,474|, a medium effect size is ∂ = |0,33|
and a low effect size is ∂ < |0,147| (Cohen, 1988). Analysis were
performed with R software, version 2.15.1.
RESULTS
Patients declared to have successfully practiced self-hypnosis at
least once every day in the great majority of the days during
month treatment. The HADS scores showed that before the treat-
ment two out of eight patients suffered from “mild” depression
while the remaining six fell in the normality range; after the
treatment all eight patients fell in the normality range for depres-
sion. Before the treatment, three patients out of eight suffered
from “mild” anxiety, one suffered from “severe” anxiety, and the
remaining four patients fell into the normality range. After the
treatment, two out of eight patients suffered from “mild” anxiety
while the six remaining had a normal score (of note, one was pre-
viously ranged as “moderate” and one was previously ranged as
“severe”). Pre and post analysis of the HADS scores showed sig-
nificant reduction in the anxiety subscale, with very high effect
sizes (where an high effect size is considered ∂ ≥ |0,474|) both
for patients (W = 36, p= 0.008; ∂ =−1) and caregivers (W = 21,
p= 0.031; ∂ =−0.75); moreover, the HADS depression subscale
showed a significant reduction in score with high effect size
(W = 28, p= 0.016; ∂ =−0.875) for the patients group only. Sig-
nificant pre-post differences were also observed in the ALSSQOL-r
average total score (W = 1, p= 0.016; ∂ = 0.75), negative emo-
tion subscale (W = 0, p= 0.008; ∂ = 1), and religiosity/spirituality
subscale (W = 1, p= 0.031; ∂ = 0.625). The interaction (W = 5,
p= 0.078; ∂ = 0.75) and physical symptoms (W = 0, p= 0.125;
∂ = 0.75) subscales’ pre-post differences were not found signif-
icant, but still showed a large effect size, whereas the bulbar
and intimacy subscales showed only a medium to small effect
size. ALSAQ-5 questionnaire did not show any significant differ-
ence before and after the treatment (W = 16, p= 0.219; ∂ = 0.25).
Patient and caregiver questionnaires mean and standard deviation
score, and pre to post treatment comparison in terms of statistical
indices are shown in Table 2.
Regarding physical symptoms, both the two patients who were
suffering from sleep disorders, four out of seven patients suffering
from muscular pain and cramps, four out of five patients who were
suffering fasciculations and each of the four patients suffering from
emotional lability declared that their symptoms improved during
the training period. A question on the perceived usefulness of the
training, ranging from 0: “not useful at all” to 5: “very useful,”
showed an average score of 4.25 (SD= 0.71).
DISCUSSION
In contrast with the prolific scientific literature addressed to inves-
tigate the psychological impact of ALS on affected patients (Fel-
goise et al., 2010; Palmieri et al., 2010a; Lulé et al., 2012; Pagnini,
2012), the need to outline research on efficacy of psychologi-
cal intervention has recently emerged (Pagnini et al., 2012). The
current pilot study represents a preliminary response to such a
relevant issue. Our psychological treatment, on a small patient
sample size, was focused on hypnosis-based domiciliary inter-
vention (hypnosis intervention and self-hypnosis training) and
was designed to address three related goals: to assess the effect
of such intervention on both reducing psychological suffering in
ALS patients and giving relief from physical symptoms of the dis-
ease and consequently contributing to a positive psychological
impact on caregivers. Our findings provided a clearly encouraging,
although initial, support for using hypnosis to manage psycholog-
ical and some physical consequences of ALS. In particular, results
showed ALS patient improvements in depressive, anxiety sympto-
matology, and in general quality of life after 1 month treatment.
Moreover, relevant pre to post treatment improvements in pain,
disorders, emotional lability, and fasciculations were reported and
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P (WilcoxonW index) Pre-post effect
size (Cliff’s delta)
HADS anxiety 8.12 (4.58) 4.5 (4.44) 0.008** (36) −1
HADS depression 4.87 (2) 3 (2.33) 0.016* (28) −0.87
ALSSAQOL-r negative emotions 7.38 (1.21) 8.44 (0.60) 0.008** (0) −1
ALSSAQOL-r interaction 7.49 (1.21) 8.21 (1.17) 0.078 (5) 0.75
ALSSAQOL-r intimacy 6.21 (2.17) 6.28 (2.25) 0.437 (6.5) 0.25
ALSSAQOL-r religiousness 8.10 (2.34) 7.12 (1.76) 0.031* (1) 0.62
ALSSAQOL-r physical symptoms 7.06 (1.96) 7.71 (1.53) 0.125 (0) 0.75
ALSSAQOL-r bulbar functioning 6.82 (0.96) 6.95 (1.01) 0.250 (2) 0.37
ALSSAQOL-r total score 6.95 (0.99) 7.68 (0.89) 0.016* (1) 0.75
ALSAQ-5 45 (17.52) 41.87 (20.86) 0.219 (16) 0.25
CAREGIVER OUTCOMEVARIABLES (QUESTIONNAIRE SCORES)
HADS anxiety 8 (4.66) 6.12 (3.88) 0.031* (21) −0.75
HADS depression 4.62 (4.78) 3.25 (5.33) 0.22 (22) −0.37
HADS, hospital anxiety and depression scale; ALSSQOL-r, amyotrophic lateral sclerosis specific quality of life – revised; ALSAQ-5, 5-items amyotrophic lateral sclerosis
assessment questionnaire.
Significant results are in bold; *p<0.05; **p<0.01.
attributed by patients to hypnosis-based intervention and self-
hypnosis training. A satisfaction level from good to extreme was
finally reported by patients involved in our study, confirming
the appreciation and the applicability of the treatment. Caregiver
depression and anxiety levels were observed to decrease during
1 month patient treatment, and such positive trend was attributed
by them to patient gained psychological wellbeing.
Before the beginning of the treatment, two of our patients were
classified as affected by “mild” depression and half of them as
affected by “mild” to “severe” level of anxiety. Moreover, at the
end of the treatment, the great majority of patients qualitatively
showed, from a clinical point of view, a clear amelioration in such
aspects, and the global psychometric analyses, calculated on HADS
questionnaire scores, confirmed such clinical evidence. These find-
ings on patient psychopathological remission, even if should be
considered with caution at this preliminary stage of investigation,
are undoubtedly of great interest for clinicians. As an example,
depression and anxiety appear to be strongly related in the disease:
Atassi et al. (2011) found that anxiety level resulted the unique
ALS related symptom that can predict the occurrence of depres-
sion. Prevalence of depression in ALS has been reported as highly
variable, depending by specific interview methods and assessment
tools of investigation (Taylor et al., 2010), and could reach levels as
high as 75% (Wicks et al., 2007). The nature of the wide difference
in estimation of mood states in ALS is conceivably due also by
the fact that the existential despair some patient feel in the face of
their illness may be poorly described by the word of “depression.”
Their experience of overwhelming sense of demoralization, hope-
lessness, anger, and loss of meaning in the face of their mortality
is something different of feel just depressed (Blackhall, 2012).
Our study highlighted also positive psychological changes in
patients’ quality of life after the training. Both specific ALS
measures of the quality of life employed in the study, namely
the ALSSAQOL (Simmons et al., 2006) and the ALSAQ-5
(Jenkinson and Fitzpatrick, 2001; Palmieri et al., 2010b), showed a
clear improvement when comparing pre to post treatment mean
scores. In particular, the ALSSAQOL“negative emotion”and“spir-
itually/religiousness” subscales reached the psychometric signif-
icance in terms of pre to post treatment improvements, while
“interaction” and “physical symptoms” subscales appeared to be
marginally significant. In the palliative care field, improving or
maintain global quality of life is considered the crucial challenge
in patients whose disease is not responsive to curative treatment as
ALS. World Health Organization (WHO) scientific panel clearly
established that the main objective of palliative care is achievement
of the best quality of life for patients and their families until death
(Doyle et al., 2003).
Interestingly, qualitative positive results have been emerged
also in the disease secondary symptomatology, as it is perceived
by patients. All of them declared to have perceived an improve-
ment, from mild to extreme depending on cases, in pain, sleep
disorders emotional lability, or fasciculation syndrome, whereas
there was an occurrence before treatment. Since ALS devastating
impact on motor system and dysphagic/dysartric, respiratory dys-
functioning, the impression is that secondary symptoms patient
suffering have been underestimated by scientific attentional focus.
However, recent clinical/epidemiological investigation highlighted
such relevant disease consequences for patients. In particular, Chiò
et al. (2012), in a wide epidemiological study, show that pain
(e.g., muscle spasms, contractures, spasticity, abnormal stresses
on the musculoskeletal system imposed by weak musculature)
is frequent in all stages of ALS, but it often goes underrecog-
nized and undertreated, recommending research efforts toward
the appropriate ALS pain treatment. Our intervention proto-
col could be interpreted as addressed in such direction as well.
The arena in which the hypnosis has probably proved its efficacy
most adequately is, indeed, that of hypnotically induced analgesia,
providing reduction of both chronic (e.g., cancer) and acute (e.g.,
painful medical procedure) pain (Freeman et al., 1999). As for ALS
sleep disorders (resulting from factors such as reduced mobility,
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muscle cramps and anxiety, restless legs, and increased myoclonic
activity), it may produce daytime symptoms and impairment
activities of daily living and can be further affected by an increased
incidence of depression (Hetta and Jansson, 1997). In emotional
lability and fasciculation syndrome, respectively underestimated
source of deep embarrassment (Palmieri et al., 2009) and physical
discomfort (Rana et al., 2009), as well for pain and sleep disorders,
seems to play a psychological etiopathogenetic non-neglectable
role (Palmieri et al., 2009; Rana et al., 2009). As a final confirmation
of the treatment approval, in the overall judgment of satisfaction
we asked to the patients, all of them declared a good from extreme
satisfaction.
Relevant improvement in terms of depression and anxiety
reduction, measured with the same patient assessment tools, was
reported by caregivers. When asked, the great majority of them
stated they were satisfied of hypnotic treatment and self-hypnosis
training patient positive outcome, and that the improvement on
patient psychological functioning, according to them, has lead to
a probable effect on their own mood tone as well. The impact
of patient suffering on family caregivers is a further understudied
but important topic. Associations of patient distress with caregiver
negative affect has recently been shown by some authors (Chiò
et al., 2005; Gauthier et al., 2007; Boerner and Mock, 2012). On
the other hand, patient’s loss of physical functions was positively
related with caregiver burden, anxiety, and somatic expression of
depression (Pagnini et al., 2010a).
Our findings on treatment efficacy, in their globality, could
appear surprising, but it should be mentioned the number of
Authors who have recently enhanced the potentiality of hypnosis-
based treatment, and, in general, mind-body techniques, leading to
a rapid improvement on anxiety, and depression especially when
they are reactive to a medical condition (Shih et al., 2009; Willem-
sen et al., 2010; Plaskota et al., 2012). Specifically, in the realm
of neurological disorders, hypnosis has been reported as an effec-
tive adjunctive treatment for organic brain damage (Sullivan et al.,
1974), Parkinson disease (Wain et al., 1990), stroke (Holroyd and
Hill, 1989), peripheral nerve lesions (Pajntar et al., 1980), cases
of organic paralysis (Lucas et al., 1981), various type of dysto-
nia (De Benedittis, 1996), multiple sclerosis (Jensen et al., 2009,
2011), migraine (Ezra et al., 2012), and fibromialgy (Bernardy
et al., 2011).
Although our results show promising and exciting insights, the
study suffers of a number of limitations, including the typical ones
that naturally characterize pilot studies. Primary among them, the
small sample size have limited our ability to detect whole treatment
effect from a psychometric point of view. A further criticism is the
lack of a different treatment condition (e.g., a different mind-body
intervention or psychopharmacological treatment) that controls
for the effects of time, placebo condition, and expectancy effect.
Lastly, additional measurement at pre treatment level in order to
investigate psychological traits such as personality profile, attach-
ment style and hypnotic absorption, dissociation, and suggestion
ability could have been undoubtedly important variables to be
compared with the treatment efficacy (Primavera and Patterson,
1991). Moreover it will be relevant to consider the frequency of
self-hypnosis and verify its role in the efficacy of this kind of
treatment with ALS patients.
In conclusion, our general aim was to lay some foundations to
develop, in a future perspective, a protocol of eligible psychological
interventions for ALS, “useful for a meaningful improvement in
quality of life or reduction in psychological distress in patients and
their caregivers” (Pagnini et al., 2012) and suitable to be proposed
to patients with a such peculiar condition, involving bulbar dys-
functions and that can eventually lead to a locked-in syndrome.
Despite the pilot study limitations, the findings provide clear sup-
port for the potential efficacy of hypnosis-based intervention to
cope with devastating consequences of ALS. Further longitudinal
researches using larger sample to help determine the reliability of
the current findings are warranted.
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